Supreme Court Freezes 5th Circuit Order Blocking Mail-Order MifepristoneMay 22, 2026Legal NewsThe Supreme Court indefinitely froze a 5th Circuit ruling that would have ended mail-order mifepristone access, as Alito and Thomas dissented and the Comstock Act emerged as a new front.
Fifth Circuit Blocks Telehealth and Mail Access to Mifepristone NationwideMay 17, 2026Legal NewsThe Fifth Circuit reinstated in-person dispensing rules for mifepristone on May 1, blocking telehealth and mail access nationwide and triggering emergency Supreme Court appeals.
Supreme Court Stays 5th Circuit Order Restoring Mifepristone Dispensing RulesMay 17, 2026Legal NewsThe Supreme Court stayed a 5th Circuit order that would have ended mail-order mifepristone access, with Thomas invoking the Comstock Act in a notable dissent.
5th Circuit Bans Mifepristone Mail Distribution; Drugmakers Rush to Supreme CourtMay 16, 2026Legal NewsThe Fifth Circuit voided FDA's 2021 mail-dispensing rule for mifepristone, banning telehealth prescribing nationwide. The Supreme Court issued an emergency stay May 14.
Supreme Court Stays Fifth Circuit Mifepristone Ruling, Preserving Telehealth AccessMay 16, 2026Legal NewsThe Supreme Court stayed the Fifth Circuit's mifepristone telehealth ban on May 14, preserving mail-order access while two justices raised the Comstock Act as a future threat.
Supreme Court Blocks Fifth Circuit Order Restricting Mail-Order Mifepristone AccessMay 15, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit ruling that would have banned mail-order mifepristone, with seven justices granting relief and Alito dissenting in sharp terms.
22-State Coalition Urges Supreme Court to Stay Fifth Circuit Mifepristone RulingMay 6, 2026Law and PolicyA 22-state coalition and Connecticut filed separate amicus briefs asking the Supreme Court to stay the Fifth Circuit's mifepristone in-person dispensing ruling before a May 11 deadline.
Alito Issues One-Week Stay Blocking Fifth Circuit Mifepristone RulingMay 6, 2026Law and PolicyJustice Alito issued a one-week administrative stay on May 4, 2026, blocking a Fifth Circuit ruling that would have banned mail-order mifepristone access nationwide.